Diabetes, Metabolic Syndrome and Obesity

SJR Rank #5,876H-index: 80SJR: 0.890Best quartile: Q2Open AccessAPC: US$2,836Listed in DOAJ
Journal website: aims, scope and author guidelines
Publisher

Dove Medical Press Ltd

Country

New Zealand

Type

journal

SJR by Edition

2022202500.250.50.751

Subject Categories

  • Internal MedicineQ2
  • PharmacologyQ2

Areas: Medicine · Pharmacology, Toxicology and Pharmaceutics

Most published research topics

Diabetes, Cardiovascular Risks, and LipoproteinsDiabetes Treatment and ManagementAdipokines, Inflammation, and Metabolic DiseasesDiabetes Management and ResearchLiver Disease Diagnosis and TreatmentDiabetes Management and EducationChronic Kidney Disease and DiabetesBariatric Surgery and OutcomesMetabolism, Diabetes, and CancerDiet and metabolism studies

Source: OpenAlex

Publication Statistics

2025 Docs3-Year DocsCitable Docs03006009001200

Documents per Year

202220250100200300400

Detailed Information

ISSN

1178-7007

SJR Best Quartile

Q2

Region

Pacific Region

Citations per Document (2 years)

3.35

References per Document

45.89

Coverage

2009-2026

Scope

An international, peer-reviewed, open access, online journal. The journal is committed to the rapid publication of the latest laboratory and clinical findings in the fields of diabetes, metabolic syndrome and obesity research. Original research, review, case reports, hypothesis formation, expert opinion and commentaries are all considered for publication.

Metrics from SCImago Journal Rank 2025. View on SCImago